8-K current report · filed Sep 30, 2026

Inogen Inc (INGN) 8-K Current Report: September 30, 2026

Item 1.01Item 8.01Item EX-99.1Item 7.01INGN overview

Short answer

Inogen Inc (INGN) filed an 8-K current report with the SEC on September 30, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). Inogen selling substantially all U.S. oxygen rental business assets to Rotech Healthcare.

Inogen Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Inogen selling substantially all U.S. oxygen rental business assets to Rotech Healthcare
  • Purchase price up to approximately $24.8 million, subject to post-closing reconciliation
  • Consideration payable in six installments, creating staged cash proceeds
  • Transfer includes inventory and related patient records, reducing Inogen’s U.S. rental operations footprint
  • Customary closing conditions mean transaction completion remains pending

Item 7.01 · Regulation FD Disclosure

  • Press release announces a Purchase Agreement with Rotech Healthcare Inc
  • Separate product supply agreement with Rotech, creating an ongoing commercial relationship
  • Conditional amendment to Inogen’s existing share repurchase program, subject to Item 8.01 terms
  • Exhibit 99.1 contains the transaction details investors need to assess financial impact

Item 8.01 · Other Events

  • Repurchase authorization would rise from $30.0 million to $45.0 million upon Transaction closing
  • Authorization extension through June 30, 2028, from December 31, 2027
  • $45.0 million represents total authorization, including prior repurchases, not incremental capacity
  • Amendment remains conditional; failed Transaction leaves existing program unchanged

Item EX-99.1 · Exhibit EX-99.1

  • Divestiture of U.S. oxygen rental assets to Rotech for estimated cash consideration up to $25 million, expected closing Q4 2026
  • Rental Business generated $24.3 million revenue in H1 2026, down 9.8% year over year
  • New long-term Rotech supply agreement expands Inogen concentrator access through a national distribution network
  • Rental operations expected classified as discontinued operations beginning Q3 2026, reshaping reported continuing-operations results
  • Share repurchase authorization increased $15 million to $45 million, conditional on closing and expiring June 30, 2028

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Inogen Inc 8-K filings

Get the next INGN 8-K as it lands

Follow INGN for push alerts, or ask the research agent what this filing means.